Introduction
Stereotactic biopsy is a simple and precise procedure that neurosurgeons have used for more than a century. [1] [2] [3] [4] Since its emergence, the technique has combined and adapted its essential principles using the current technological advances. Today it constitutes the least invasive strategy to obtain a histologic sample for diagnosis and therapeutic evaluation of patients with intracranial lesions. Stereotactic biopsy has a high percentage of accuracy and a low percentage of complications. Its accuracy was demonstrated in numerous studies, with an average diagnostic yield of $ 90 to 95%. [5] [6] [7] The large published series reflect an
Materials and Methods

Patients and Data Collection
The clinical histories and neuroimaging tests of 407 patients who underwent stereotactic biopsy in the past 34 years between 1982, when this technique was first used in our institution, and 2016 were retrieved and evaluated. Fifty baseline patient and case variables were entered into a database and analyzed. The variables included the demographic and clinical characteristics of the patients, the anatomical and radiologic characteristics of the brain lesions, [17] [18] [19] [20] the surgical technique, the diagnosis and therapeutic course, and the prognosis.
Surgical Planning
Inclusion and Exclusion Criteria
The inclusion and exclusion criteria considered when determining whether a patient was a candidate for stereotactic biopsy were previously described. 5, 6, 8, 10, 12, 14, 15, 21 
Surgical Technique
The surgical methodology used throughout the decades was determined by the equipment available in the hospital at the time. We identified three methodological periods.
Period 1 (1982-1991)
During this first stage, the Todd-Wells stereotactic device (Integra Radionics, Burlington, Massachusetts, United States), 22 and the Backlund spiral needle, 8 the first unit made by the senior author (J.H.V.), were used. As a peculiarity of this period, it is worth mentioning the use of an impedance meter (Integra Radionics , Burlington, Massachusetts, United States) to estimate tissue resistance throughout the selected trajectory. The radiologic equipment included portable radiographic devices (C-arm; Philips, Amsterdam, The Netherlands) to which a 16-slice CT scanner (Siemens, Berlin, Germany) was added in 1985.
Initially, an angiogram was used to perform the calculations to reach the target, but after the acquisition of CT, the calculations were performed by super positioning between the radiographic images and the brain CT scan. The coordinates were obtained by locally developed MS-DOS application (►Fig. 1a, 1b). 25 were used.
The hospital had a 64-slice CT scan (General Electric, Boston, Massachusetts, United States) and a 3T MRI (General Electric, Boston, Massachusetts, United States).
In most cases, targets were established on the most suitable MRI sequence, which was later fused with a stereotactic CT scan. The coordinates were obtained with Framelink and the Cranial v.3.0 planning program (Medtronic, Minneapolis, United States) (►Fig. 3a).
The most experienced stereotactic neurosurgeon retired during this period.
During all three periods, the biopsy technique consisted of making a drill or a burr hole and obtaining tissue samples comprising three or four cylinders at different depths of the trajectory of the needle on its way across the target, or targets, on the lesion.
Patients were monitored in the intensive care unit or recovery room for 24 hours after the biopsy was obtained. During the first two periods, postoperative control brain CT scans were only performed if there was a clinical deterioration of the patient, whereas in period 3, brain CT scans were ordered routinely 24 hours after the intervention.
Anesthetic Technique
Local anesthesia (bupivacaine 0.25% plus epinephrine) and light sedation were used during the surgical intervention. Exceptionally, general anesthesia was used in some pediatric patients or in patients with clinically significant mental alteration.
Histopathologic Evaluation
Intraoperative histologic evaluation was performed on tissue smears. If there was no evidence of abnormal tissue, additional samples were obtained. The definitive histopathologic evaluation was performed on fixed and stained tissue.
The World Health Organization's Classification of Tumours of the Central Nervous System (2007) was used, 27 not the recent 2016 classification, 28 due to the period in which the biopsies were performed and the pathologic diagnoses were made. Nondiagnostic biopsies were classified as either inconclusive or negative following previously described criteria. 
Statistical Analysis
Statistical analysis was performed with SPSS v. 23 for Windows (SPSS Inc., Chicago, Illinois, United States) using parametric tests. Descriptive statistics were reported for qualitative and quantitative variables. The tests used for the study of the statistical association between two independent variables were the chi-square test, with correction by means of the Fisher exact test when necessary, for the qualitative variables, and the Student t test and analysis of variance, with the Bonferroni test, for the analysis of the association between qualitative and quantitative variables with two or more than two categories, respectively. The association of two or more independent variables was tested by binary logistic regression (multivariate analysis). The results were considered statistically significant for p < 0.05.
Results
Demographic Characteristics: Patients and Pathologies
We analyzed a total of 407 patients who had undergone stereotactic biopsy in our department, 143 in period 1 (35.2%), 213 in period 2 (52.3%), and 51 in period 3 (12.5%).
The average age of the patients in the series was 53.8 years. Most of the patients were in the fifth and sixth decades of life (47.6%; n ¼ 194), with an average of 57 years of age Frame-based Stereotactic Biopsy and Diagnostic Yield Lara-Almunia, Hernandez-Vicente 151 (range: 3-86 years). Fourteen (3.4%) were pediatric (patients 16 years of age). The sex ratio was 1.8:1, with 265 men (65.1%) and 142 women (34.9%).
The most frequent presenting symptoms were seizures in 24.6% (n ¼ 100), motor deficit in 24.3% (n ¼ 99), and intellectual function disorders in 14.3% (n ¼ 58). Neurologic examinations found a motor deficit in 31.2% (n ¼ 127), followed by the absence of findings in 27.8% (n ¼ 113), intracranial hypertension in 16.2% (n ¼ 66), and intellectual functioning disorders in 11.5% (n ¼ 47).
Most lesions were on the left side (41.8%; n ¼ 170). The frontal region was the most frequently biopsied anatomical region (24.8%; n ¼ 101), and the cerebellum (1%; n ¼ 4) and brainstem (1%; n ¼ 4) were the least.
After histologic evaluation, the most frequently diagnosed pathologies were tumor in 78.8% (n ¼ 321), followed by vascular pathology (i.e., hemorrhagic or ischemic stroke) in 5.4% (n ¼ 22), radionecrosis in 0.5% (n ¼ 2), and neurologic pathology (multiple sclerosis) in 0.2% (n ¼ 1). The most frequently diagnosed tumor was a high-grade glioma (42.8%; n ¼ 174); the biopsies were nondiagnostic in 9.6% (n ¼ 39).
Forty patients (9.8%) had symptomatic intracranial hemorrhages (worsened the level of consciousness and/or produced new neurologic deficits after the biopsy). Most of those patients improved significantly in the following days. Twenty-three of the patients (57.5%) were discharged with a Karnofsky performance status > 80. The procedure-associated mortality was 0.98% (n ¼ 4). ►Table 1 shows the demographic characteristics of the patients and pathologies in the series, and according to the methodological period.
Diagnostic Yield and Related Variables
The overall diagnostic yield of our stereotactic biopsies was 90.4%, and there were no statistically significant differences in the diagnostic yields among the three methodological periods (p ¼ 0.864).
Lesion Topography
Biopsies performed on deep lesions, specifically lesions located in diencephalic structures, had a worse diagnostic yield (p ¼ 0.043). In contrast, the biopsies of brainstem lesions (1%; n ¼ 4) reached a 100% diagnostic yield.
Radiologic Characteristics of the Lesion
Biopsies of hypodense lesions without contrast enhancement (18.9%; n ¼ 77), biopsies of lesions with patent and extensive edema (45.4%; n ¼ 185), patent and extensive necrosis (1%; n ¼ 251), or biopsies of largely cystic lesions (21.6%; n ¼ 88) showed a lower diagnostic yield (p < 0.05).
Multivariate logistical regression analysis showed that both the absence of contrast enhancement, with an odds ratio (OR) of 0.313 (p ¼ 0.002), and the presence of a large cystic component, with an OR of 0.396 (p ¼ 0.014), were configured as predictor variables of a worse diagnostic yield of the biopsy.
Surgical Procedure Peculiarities
On the one hand, and in relation to the number of targets, because we obtained between three and four cylinders in each target routinely, we decided to analyze whether the establishment of one or more targets with their respective trajectories on different lesion points affected the diagnostic yield of the technique. In the series, we found no statistical significance (p ¼ 0.054). However, during period 1, we observed a greater diagnostic yield if the samples were obtained from two or more targets (p ¼ 0.021).
On the other hand, the performance of an intraoperative biopsy was requested on 92.1% of the procedures (n ¼ 375). We obtained 7.2% of nondiagnostic biopsies if the intraoperative smear was made compared with 37.5% of nondiagnostic biopsies if it was not made (p ¼ 0.024).
Neurosurgeoń s Experience
In this series, the biopsy tissue was obtained from 80.8% of the patients (n ¼ 329) by a neurosurgeon with experience in stereotactic techniques. The percentages were 80.4% (n ¼ 115) in period 1, 89.6% (n ¼ 191) in period 2, and 70.6% (n ¼ 36) in period 3.
The analysis showed that 16.6% of the nondiagnostic biopsies were obtained by an inexperienced neurosurgeon compared with 6.9% obtained by an experienced 
Nondiagnostic Biopsies
Overall, 39 of the biopsies (9.6%) were nondiagnostic. Of those, 2% (n ¼ 8) were inconclusive, and 7.6% (n ¼ 31) were negative.
In these patients, the stereotactic biopsy was repeated once in 71.7% of the cases (n ¼ 28) and twice in 10.2% of the cases (n ¼ 4).
In this series of 407 patients, 82 (20.1%) underwent craniotomies after the biopsy. The main reasons were either surgical resection of the lesion was considered the best treatment strategy after histologic results (64.7%; n ¼ 53) or there were doubts about these histologic results because of the clinical condition and the neuroimaging tests of the patient (26.8%; n ¼ 22). In seven patients (8.5%), the indication for surgery was based on not obtaining a diagnosis by stereotactic methods.
Discussion
Since the mid-20th century, stereotactic techniques have been used as one of the first minimally invasive strategies adapted to the field of neurosurgery. 
Diagnostic Yield of Stereotactic Biopsy
Successful histologic diagnosis of tissue obtained by stereotactic biopsy depends on the correct performance of the procedure, the suitability of the biopsy technique, and the adequacy of the samples obtained. In our hands, 9.6% of the biopsies were nondiagnostic. Our result is consistent with previous reports (►Table 3).
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Among its diverse indications, 64 did not find that the depth influenced the diagnostics (p > 0.05). However, studies such as those by Jain et al, in a series of only 86 cases, found that the diagnostic yield was greater in tissue obtained from the thalamus or the basal ganglia (85.4%), compared with tissue from the cerebral hemispheres (75%). 65 Our results show that increased depth of the lesion was associated with a decreased diagnostic yield (p ¼ 0.043), and we believe the large sample size facilitated obtaining this result. In relation to deep locations, brainstem biopsies should be mentioned, due to the high eloquence of the area. Both the large published series made up of pediatric and adult patients (Kickingereder et al 66 or Samadani et al) 67 and those showed diagnostic yield figures for the technique close to 100%. The consistency of diagnostic yield from this location might result from established standardized stereotactic techniques to perform the biopsies in this region and from the relatively limited pathologic differential diagnosis of brainstem lesions, especially in children. Selecting the appropriate biopsy site is an important determinant of obtaining an adequate histologic sample for evaluation. The choice of biopsy site could be influenced by the morphology of the lesion in the neuroimaging tests.
Previous studies found that biopsies performed on hypodense lesions and/or those with scarce or no contrast enhancement were the most likely to be nondiagnostic. 29, 64, [70] [71] [72] However, none of these reports were statistically significant (p > 0.05). Nevertheless, in our work we have been able to demonstrate statistically what was only a perception in those studies (p ¼ 0.004). In this patient series, biopsies of lesions without contrast enhancement, with an OR of 0.313, were 23.8% more likely to be nondiagnostic. This could be explained by the fact that most hypodense lesions without contrast uptake are generally tumors with a low degree of differentiation, and they are difficult to distinguish by other histologic findings such as gliosis.
Unlike many other studies, we included other radiologic features of the pathology in the evaluation, finding that significant edema (p ¼ 0.036) or necrosis (p ¼ 0.040) was associated with nondiagnostic biopsies. This could have resulted from difficulties in defining the lesion boundaries and consequently establishing the most appropriate biopsy site.
Biopsies of lesions with a large cystic component also had a reduced diagnostic yield (p ¼ 0.023). This feature, with an OR of 0.396, is also a predictive factor for diagnostic yield, such that the biopsies performed on lesions with a large cystic component had a 28.3% probability of being nondiagnostic. This result might be explained by the limited amount of histologically useful tissue that is generally obtained from such lesions. It may also have resulted from changes in the preplanned target after nonintentional drainage of the cystic component during the first acquisition of the histologic material. Those changes should be avoided.
The study findings stress the importance of systematic evaluation of suitable MRI sequences during the surgical planning of the biopsy to obtain a detailed map of the brain anatomy that shows the actual limits of the lesion and provides a three-dimensional image of the target, especially for deep locations.
In recent years, the routine integration of positron emission tomography (PET) with 18F-labeled fluorodeoxyglucose (FDG) in the planning of stereotactic brain biopsy has increased the technique's diagnostic yield. [73] [74] [75] Fourteen procedures in period 3 used 18 F-FDG PET/CT guidance. The patients had multiple intracranial lesions or a controversial differential diagnosis on conventional neuroimaging techniques. A diagnostic yield of 100%, transitory morbidity of 7.1% (n ¼ 1), and 0% mortality was obtained in the 14 patients.
The number of biopsy samples should be enough to arrive at a diagnosis. Jain et al 49 and Brainard et al. 76 suggested that diagnostic yield increased with the number of samples obtained, but the difference did not achieve statistical significance (p > 0.05). Obtaining samples from more than one target could facilitate determining the degree of histologic differentiation, especially in heterogeneous lesions, and could improve diagnostic yield. In this series, the overall association of the Close collaboration with the pathology laboratory is essential, and the pathologist should be aware of the clinical history of the patient, the radiologic features of the lesion, and the most probable differential diagnosis.
The selection of the target and the trajectory directly depend on the neurosurgeon. In work by authors such as Ranjan et al, it is appreciated that experienced neurosurgeons in stereotactic techniques obtained approximately half the number of nondiagnostic biopsies (2.4%) as inexperienced neurosurgeons did (5.7%). 29 Other studies did not make the same observation. 43, 45 None of these studies achieved statistical significance (p > 0.05). Nevertheless, in our study we found that inexperienced neurosurgeons obtained nearly three times more nondiagnostic biopsies (16.6%) compared with experienced neurosurgeons (6.9%), which was statistically significant (p ¼ 0.001). This fact was more remarkable in period 3 in which we had the greatest number of biopsies performed by inexperienced neurosurgeons (n ¼ 15; 29.4%). As an example, in this last period, 12 biopsies were performed on diencephalic structures. A total of 4 (33.3%) were performed by inexperienced neurosurgeons. All these biopsies were nondiagnostic. We think this result determined a worse diagnostic yield if the stereotactic biopsy was performed on diencephalic structures in this series (p ¼ 0.043). In addition, inexperienced neurosurgeons only requested intraoperative biopsies in 52.5% of the cases compared with the 87.2% requested by experienced neurosurgeons (p ¼ 0.001). Finally, with an OR of 4.049, we found that the neurosurgeon's experience was the most clear predictive factor of diagnostic yield. There was an 80.1% higher probability that the biopsy was diagnostic if it had been performed by a neurosurgeon experienced in stereotactic techniques. We believe that experience significantly influenced the period 3 results and explains why technical advances and sophistication of the equipment used did not result in statistically important improvements in the reliability and safety of the stereotactic biopsies in this period. The appropriate and thorough management of stereotactic biopsy techniques requires neurosurgeons to have a special interest in neuroradiology, to select the most useful radiologic tests before surgery, and in neuro-oncology, to possess the knowledge and clinical judgment that allows them to connect with the different specialties involved in the treatment of patients with intracranial lesions. They should also have adequate stereotactic training that provides them with in-depth knowledge of the principles of stereotactic neurosurgery, the technology related to the procedures, the use of the available instruments, as well as how to plan meticulously and carefully carry out the technique. The training would ensure fully exploiting the benefits and minimizing the risks of an extremely powerful surgical tool.
Postbiopsy Patient Management
Obtaining a nondiagnostic biopsy is an unfavorable result that should be taken into account before indicating a stereotactic biopsy. If the neurosurgeon suspects this during surgery, intraoperative biopsy, the precision of the stereotactic instruments, and the suitability of the planned target and trajectory should be evaluated and/or adjusted.
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If the surgical intervention has been completed and the final histologic diagnosis is inconclusive or ambiguous, we believe there are various management possibilities based on the clinical situation of the patient and the neuroimaging findings.
Because a stereotactic biopsy was initially considered the most suitable technique, it is reasonable to consider offering the patient a repeat biopsy. This was the course followed in 81.9% of our nondiagnostic biopsies.
If the patient refuses this option or if the lesion is located in a relatively accessible anatomical region, a craniotomy to obtain tissue for histologic study can be offered. This was the course followed in the remaining 18.1% of cases with nondiagnostic biopsies (►Fig. 4). Frame-based Stereotactic Biopsy and Diagnostic Yield Lara-Almunia, Hernandez-Vicente
Conclusions
Stereotactic biopsy constitutes a perfectly consolidated procedure in neurosurgical departments. It is a versatile technique that allows a safe and effective histologic diagnosis and therapeutic planning in patients with intracranial lesions.
Our findings confirm that obtaining more than one tissue sample and performing an intraoperative study help ensure the quality of the histologic material and thus improve the diagnostic yield of this technique. Similarly, the use of the most suitable MRI sequences during biopsy planning is required to obtain a detailed map of the lesion and its relation to the brain anatomy. This facilitates establishing the target and the most appropriate trajectory.
Technological advances achieved in the previous decades and their integration into stereotactic biopsy procedures have placed increasingly manageable instrumentation and simpler planning tools at our disposal. This has clearly made it easier to perform this neurosurgical intervention. Nevertheless, to obtain the best results, it is necessary to optimize each neurosurgeon's experience and interest in stereotactic techniques, neuroradiology, and neuro-oncology. These features are essential to determine the indication for stereotactic biopsy, the establishment of the best targets and their trajectories, and the appropriate intraoperative management of the histologic samples obtained.
